MWM
BIIB icon

Mission Wealth Management’s Biogen BIIB Stock Holding History

Mission Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Sell
1,621
-201
-11% -$37K 0.01% 609
2025
Q4 		$321K Buy
1,822
+92
+5% +$15K 0.01% 598
2025
Q3 		$242K Sell
1,730
-126
-7% -$17K ﹤0.01% 630
2025
Q2 		$233K Buy
1,856
+6
+0.3% +$748 0.01% 625
2025
Q1 		$253K Sell
1,850
-471
-20% -$67.3K 0.01% 588
2024
Q4 		$355K Buy
2,321
+254
+12% +$42.8K 0.01% 516
2024
Q3 		$401K Buy
2,067
+154
+8% +$32.2K 0.01% 474
2024
Q2 		$443K Buy
1,913
+87
+5% +$18.9K 0.01% 439
2024
Q1 		$394K Buy
1,826
+66
+4% +$15.5K 0.01% 489
2023
Q4 		$455K Sell
1,760
-16
-0.9% -$3.93K 0.01% 390
2023
Q3 		$456K Buy
1,776
+184
+12% +$49.2K 0.02% 359
2023
Q2 		$453K Sell
1,592
-3
-0.2% -$893 0.02% 360
2023
Q1 		$443K Buy
1,595
+26
+2% +$7.19K 0.02% 364
2022
Q4 		$434K Buy
1,569
+64
+4% +$18.1K 0.02% 348
2022
Q3 		$402K Sell
1,505
-38
-2% -$8.07K 0.02% 335
2022
Q2 		$315K Sell
1,543
-97
-6% -$19.8K 0.02% 385
2022
Q1 		$345K Sell
1,640
-156
-9% -$33.9K 0.02% 384
2021
Q4 		$431K Buy
+1,796
New +$462K 0.02% 350

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mission Wealth Management's BIIB Position: Q1 2026 in Review

Mission Wealth Management reduced its Biogen (BIIB) stake by 11% in Q1 2026, selling an estimated $37K and leaving 1,621 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #609.

Mission Wealth Management first reported a position in BIIB in Q4 2021 and has held it in 18 quarters since. The position peaked at $456K in Q3 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Mission Wealth Management held 1,621 shares of Biogen worth $297K as of Q1 2026.
  • Mission Wealth Management sold 201 Biogen shares in Q1 2026, an estimated $37K.
  • Biogen made up 0.01% of Mission Wealth Management's portfolio in Q1 2026, its #609 holding.
  • Mission Wealth Management first reported a position in Biogen in Q4 2021 and has held it in 18 quarters since.
  • Mission Wealth Management's Biogen position peaked at $456K in Q3 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Mission Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.